brentuximab vedotin

Ukraine

Drugs containing this active substance

  • ADCETRIS®

    The drug is intended for the treatment of adults with CD30-positive Hodgkin lymphoma (in various stages and forms), systemic anaplastic large cell lymphoma, as well as certain subtypes of T-cell lymphoma of the skin.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    brentuximab vedotin 50 mg

    ATC: L01FX05

    Manufacturer: BSP Pharmaceuticals S.p.A. (manufacturing of unpackaged product, primary packaging, quality control of finished product batches)